Shares of Johnson & Johnson JNJ, -0.44% shed 0.61% to $168.76 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX, -0.32% falling 1.42% to 4,659.03 and Dow Jones Industrial Average DJIA, -0.70% falling 0.49% to 36,113.62. This was the stock’s fourth consecutive day of losses. Johnson & Johnson closed $11.16 below its 52-week high ($179.92), which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. RHHVF, -2.06% fell 2.06% to $397.25, Merck & Co. Inc. MRK, 0.30% rose 0.15% to $81.32, and Pfizer Inc. PFE, -1.17% fell 1.96% to $55.54. Trading volume (5.9 M) remained 1.7 million below its 50-day average volume of 7.5 M.